Results
Ready-to-Use Infusion Bags: Provided weight-titrated chemotherapy bags with IV sets contributed to standardized trial results.
Patient Safety Assurance: Strict compliance with USP standards for compounding sterile chemotherapy doses.
Diversity, Equity and Inclusion (DEI): Investigational sites without chemotherapy preparation capabilities to participate were equipped, expanding the trial’s reach and enabling access to a broader and more diverse patient population.
Clinical Staff Safety and Enhanced Site Support: Reduced safety risks associated with handling hazardous drugs on-site, while freeing up clinical staff to focus on patient care and infusion processes.